Drug for rare disease may lift AVI BioPharma shares: Barron's

NEW YORK (Reuters) - AVI BioPharma Inc's shares could get a boost if its drug targeting treatment for a rare fatal form of muscular dystrophy proves to be effective in clinical drug trials, according to an article in the April 2 edition of Barron's.

Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/rhFRSZW2Ke0/us-avi-shares-idUSBRE8300BK20120401

recent news save money travel make money best news online money